-
Share
2,330 Posts.
413
27/04/21
10:26
Share
DEP Updates from AGM Presentation November 2020.
- DEP docetaxel - Was 37 now 40 (+3) - Not sure what trial figures are said to be for phase 2.
- DEP cabazitaxel - Was 17 with phase 2 first stage trail participant aim of 30 - Now 35 (+18) - appears over and above aim
- DEP Irinotecan - Phase 2 was 27 now 40 +13 - Not sure on population target
Appears to me that recruitment has gone well and at least one trial is fully recruited, anyone else have views on enrollment numbers please?
-
